183 studies found for:    cancer | Open Studies | wake forest
Show Display Options
Rank Status Study
21 Recruiting Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)
Condition: Breast Cancer
Interventions: Drug: Atorvastatin;   Drug: Placebo
22 Recruiting Trial of Acupuncture for Radiation-Induced Xerostomia in Head and Neck Cancer
Condition: Radiation-Induced Xerostomia
Interventions: Other: Standard Oral Hygiene;   Other: Standard Oral Hygiene + True Acupuncture;   Other: Standard Oral Hygiene + Sham Acupuncture
23 Recruiting Paclitaxel and Pembrolizumab in Treating Patients With Refractory Metastatic Urothelial Cancer
Condition: Transitional Cell Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Paclitaxel;   Biological: Pembrolizumab
24 Recruiting Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer
Conditions: Ductal Breast Carcinoma in Situ;   Lobular Breast Carcinoma in Situ;   Male Breast Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Dietary Supplement: omega-3 fatty acid;   Other: placebo;   Other: laboratory biomarker analysis
25 Recruiting Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
Conditions: Metastatic Breast Cancer;   Leptomeningeal Disease
Intervention: Drug: High-dose Methotrexate (8 gm/m2; HD-MTX)
26 Recruiting Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy
Conditions: Current Smoker;   Head and Neck Squamous Cell Carcinoma;   Hypopharyngeal Squamous Cell Carcinoma;   Laryngeal Squamous Cell Carcinoma;   Nasopharyngeal Carcinoma;   Oral Cavity Squamous Cell Carcinoma;   Oropharyngeal Squamous Cell Carcinoma
Interventions: Drug: Bupropion Hydrochloride;   Other: Laboratory Biomarker Analysis;   Drug: Nicotine Replacement;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration;   Drug: Varenicline
27 Not yet recruiting Internet-Delivered Positive Affect Program in Managing Emotion in Young Adult Cancer Survivors
Condition: Cancer Survivor
Interventions: Other: Internet-Based Intervention;   Procedure: Quality-of-Life Assessment;   Other: Questionnaire Administration;   Behavioral: Telephone-Based Intervention
28 Recruiting Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Promyelocytic Leukemia
Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities;   Adult Acute Myeloid Leukemia With Del(5q);   Adult Acute Myeloid Leukemia With Inv(16)(p13;q22);   Adult Acute Myeloid Leukemia With t(15;17)(q22;q12);   Adult Acute Myeloid Leukemia With t(16;16)(p13;q22);   Adult Acute Myeloid Leukemia With t(8;21)(q22;q22);   Adult Acute Promyelocytic Leukemia (M3);   Childhood Acute Promyelocytic Leukemia (M3);   Recurrent Adult Acute Myeloid Leukemia;   Recurrent Childhood Acute Myeloid Leukemia
Interventions: Drug: gemtuzumab ozogamicin;   Other: laboratory biomarker analysis
29 Recruiting Evaluation of Loratadine for G-CSF Induced Bone Pain in Patients With Hematologic Malignancies
Conditions: Leukemia;   Lymphoma
Intervention: Drug: Loratadine
30 Recruiting Palliative Radiation Therapy in Reducing Pain in Patients With Bone Metastasis
Conditions: Malignant Neoplasm;   Metastatic Malignant Neoplasm in the Bone;   Pain
Interventions: Radiation: External Beam Radiation Therapy;   Radiation: Palliative Radiation Therapy;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration
31 Recruiting Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors
Conditions: Astrocytoma;   Glioma;   Oligodendroglioma
Interventions: Biological: Hepatitis A Vaccine;   Other: Laboratory Biomarker Analysis;   Biological: Tetanus Toxoid Vaccine;   Biological: Trivalent Influenza Vaccine
32 Not yet recruiting Preparatory Work to Assess Adherence to Oral Chemotherapy
Condition: Chronic Myeloid Leukemia
Intervention:
33 Recruiting Donor Stem Cell Transplant Followed by Cyclophosphamide in Treating Patients With Hematological Diseases
Conditions: Graft Versus Host Disease;   Hematopoietic/Lymphoid Cancer
Interventions: Drug: fludarabine phosphate;   Drug: busulfan;   Drug: cyclophosphamide;   Procedure: allogeneic hematopoietic stem cell transplantation;   Drug: tacrolimus;   Drug: mycophenolate mofetil
34 Recruiting CIP-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Granulocytic Sarcoma
Conditions: Granulocytic Sarcoma;   Recurrent Adult Acute Myeloid Leukemia
Interventions: Drug: 6,8-Bis(benzylthio)octanoic Acid;   Drug: Cytarabine;   Procedure: Hematopoietic Cell Transplantation;   Drug: Mitoxantrone Hydrochloride
35 Not yet recruiting Simvastatin in Overcoming Chemotherapy Resistance in Patients With Relapsed or Refractory Multiple Myeloma
Conditions: Recurrent Plasma Cell Myeloma;   Refractory Plasma Cell Myeloma
Interventions: Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment;   Drug: Simvastatin
36 Not yet recruiting Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil - WF 97116
Conditions: Cognitive Dysfunction;   Memory Impairment
Interventions: Drug: Donepezil 5 mg;   Drug: Placebo
37 Recruiting The Use of Integra in Coverage of Radial Forearm Free Flap Donor Site Defect
Condition: Head and Neck Cancer
Interventions: Device: Integra plus STSG;   Procedure: STSG
38 Not yet recruiting Selinexor With Induction, Consolidation, and Maintenance Therapy in Treating Older Patients With Acute Myeloid Leukemia
Condition: Untreated Adult Acute Myeloid Leukemia
Interventions: Drug: Cytarabine;   Drug: Daunorubicin Hydrochloride;   Drug: Selinexor
39 Recruiting CPI-613 in Treating Patients With Myelodysplastic Syndromes Who Failed Previous Therapy
Condition: Previously Treated Myelodysplastic Syndromes
Intervention: Drug: 6,8-bis(benzylthio)octanoic acid
40 Recruiting Metabolic Changes in Blood Samples From Patients With Acute Myeloid Leukemia
Conditions: Recurrent Adult Acute Myeloid Leukemia;   Untreated Adult Acute Myeloid Leukemia
Interventions: Other: Cytology Specimen Collection Procedure;   Other: Laboratory Biomarker Analysis

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.